200 related articles for article (PubMed ID: 18855583)
1. Fatty aspirin: a new perspective in the prevention of dementia of Alzheimer's type?
Pomponi M; Di Gioia A; Bria P; Pomponi MF
Curr Alzheimer Res; 2008 Oct; 5(5):422-31. PubMed ID: 18855583
[TBL] [Abstract][Full Text] [Related]
2. Dietary DHA and health: cognitive function ageing.
Cardoso C; Afonso C; Bandarra NM
Nutr Res Rev; 2016 Dec; 29(2):281-294. PubMed ID: 27866493
[TBL] [Abstract][Full Text] [Related]
3. Docosahexaenoic acid protects from amyloid and dendritic pathology in an Alzheimer's disease mouse model.
Cole GM; Frautschy SA
Nutr Health; 2006; 18(3):249-59. PubMed ID: 17180870
[TBL] [Abstract][Full Text] [Related]
4. Is Alzheimer's disease a synaptic disorder?
Pomponi M; Bria P; Pomponi M
J Alzheimers Dis; 2008 Feb; 13(1):39-47. PubMed ID: 18334755
[TBL] [Abstract][Full Text] [Related]
5. Docosahexaenoic acid and synaptic protection in Alzheimer's disease mice.
Oster T; Pillot T
Biochim Biophys Acta; 2010 Aug; 1801(8):791-8. PubMed ID: 20211757
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of n-3 fatty acid-mediated development and maintenance of learning memory performance.
Su HM
J Nutr Biochem; 2010 May; 21(5):364-73. PubMed ID: 20233652
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective and ameliorative actions of polyunsaturated fatty acids against neuronal diseases: beneficial effect of docosahexaenoic acid on cognitive decline in Alzheimer's disease.
Hashimoto M; Hossain S
J Pharmacol Sci; 2011; 116(2):150-62. PubMed ID: 21606627
[TBL] [Abstract][Full Text] [Related]
8. The pleiotropic effects of omega-3 docosahexaenoic acid on the hallmarks of Alzheimer's disease.
Belkouch M; Hachem M; Elgot A; Lo Van A; Picq M; Guichardant M; Lagarde M; Bernoud-Hubac N
J Nutr Biochem; 2016 Dec; 38():1-11. PubMed ID: 27825512
[TBL] [Abstract][Full Text] [Related]
9. Long-chain polyunsaturated fatty acids (LCPUFA) from genesis to senescence: the influence of LCPUFA on neural development, aging, and neurodegeneration.
Janssen CI; Kiliaan AJ
Prog Lipid Res; 2014 Jan; 53():1-17. PubMed ID: 24334113
[TBL] [Abstract][Full Text] [Related]
10. Why docosahexaenoic acid and aspirin supplementation could be useful in women as a primary prevention therapy against Alzheimer's disease?
Pomponi MF; Gambassi G; Pomponi M; Di Gioia A; Masullo C
Ageing Res Rev; 2011 Jan; 10(1):124-31. PubMed ID: 20920611
[TBL] [Abstract][Full Text] [Related]
11. Reduced blood-brain barrier expression of fatty acid-binding protein 5 is associated with increased vulnerability of APP/PS1 mice to cognitive deficits from low omega-3 fatty acid diets.
Pan Y; Choy KHC; Marriott PJ; Chai SY; Scanlon MJ; Porter CJH; Short JL; Nicolazzo JA
J Neurochem; 2018 Jan; 144(1):81-92. PubMed ID: 29105065
[TBL] [Abstract][Full Text] [Related]
12. Docosahexaenoic Acid-Phosphatidylcholine Improves Cognitive Deficits in an Aβ23-35-Induced Alzheimer's Disease Rat Model.
Qu MH; Yang X; Wang Y; Tang Q; Han H; Wang J; Wang GD; Xue C; Gao Z
Curr Top Med Chem; 2016; 16(5):558-64. PubMed ID: 26268328
[TBL] [Abstract][Full Text] [Related]
13. Folic acid and polyunsaturated fatty acids improve cognitive function and prevent depression, dementia, and Alzheimer's disease--but how and why?
Das UN
Prostaglandins Leukot Essent Fatty Acids; 2008 Jan; 78(1):11-9. PubMed ID: 18054217
[TBL] [Abstract][Full Text] [Related]
14. Docosahexaenoic acid disrupts in vitro amyloid beta(1-40) fibrillation and concomitantly inhibits amyloid levels in cerebral cortex of Alzheimer's disease model rats.
Hashimoto M; Shahdat HM; Yamashita S; Katakura M; Tanabe Y; Fujiwara H; Gamoh S; Miyazawa T; Arai H; Shimada T; Shido O
J Neurochem; 2008 Dec; 107(6):1634-46. PubMed ID: 19014387
[TBL] [Abstract][Full Text] [Related]
15. Docosahexaenoic acid inhibits ischemic stroke to reduce vascular dementia and Alzheimer's disease.
Yamagata K
Prostaglandins Other Lipid Mediat; 2023 Aug; 167():106733. PubMed ID: 37028469
[TBL] [Abstract][Full Text] [Related]
16. Repetitive transcranial magnetic stimulation (rTMS) influences spatial cognition and modulates hippocampal structural synaptic plasticity in aging mice.
Ma J; Zhang Z; Kang L; Geng D; Wang Y; Wang M; Cui H
Exp Gerontol; 2014 Oct; 58():256-68. PubMed ID: 25172625
[TBL] [Abstract][Full Text] [Related]
17. Omega-3 fatty acids and dementia.
Cole GM; Ma QL; Frautschy SA
Prostaglandins Leukot Essent Fatty Acids; 2009; 81(2-3):213-21. PubMed ID: 19523795
[TBL] [Abstract][Full Text] [Related]
18. Synaptic Plasticity, Dementia and Alzheimer Disease.
Skaper SD; Facci L; Zusso M; Giusti P
CNS Neurol Disord Drug Targets; 2017; 16(3):220-233. PubMed ID: 28088900
[TBL] [Abstract][Full Text] [Related]
19. Omega-3 fatty acids and brain resistance to ageing and stress: body of evidence and possible mechanisms.
Denis I; Potier B; Vancassel S; Heberden C; Lavialle M
Ageing Res Rev; 2013 Mar; 12(2):579-94. PubMed ID: 23395782
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic reversal of neurogenic and neuroplastic abnormalities and cognitive impairments without affecting Aβ and tau pathologies in 3xTg-AD mice.
Blanchard J; Wanka L; Tung YC; Cárdenas-Aguayo Mdel C; LaFerla FM; Iqbal K; Grundke-Iqbal I
Acta Neuropathol; 2010 Nov; 120(5):605-21. PubMed ID: 20697724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
